New Amicus Brief Urges SCOTUS to Take Up Patent Eligibility Law
shot by IP News Shots / 8:09 pm on 03 March, 2021
In one of the many amicus briefs filed recently, attorneys have asked the US Supreme Court to take up the patent eligibility law. They highlighted that the great divide among the full Federal Circuit regarding whether an American Axle & Manufacturing Inc. ‘s driveshaft patent should have been invalidated is proof that the Circuit needs help.
Read more at: https://www.law360.com/newyork/articles/1353277/justices-told-fed-circ-crying-out-for-patent-eligibility-help
Industry: Automobiles
CNIPA Releases ‘Measures on Regulating Patent Applications’ Draft
shot by IP News Shots / 6:54 pm on 15 February, 2021
The China National Intellectual Property Administration (CNIPA) has released the ‘Measures on Regulating Patent Applications’ draft for comment. The draft describes abnormal patent applications, associated behaviors, and penalties for these behaviors. Notably, these measures and simultaneous elimination of monetary incentives for patent filings should reduce the total number of applications, especially abnormal patents filed in the country.
Read more at: https://www.natlawreview.com/article/china-issues-draft-measures-regarding-regulation-patent-applications-to-crack-down
Industry: Others
Indian Government Plans to Abolish Five Appellate Tribunals Under New Bill
shot by IP News Shots / 6:44 pm on 15 February, 2021
The Indian government plans to abolish five appellate tribunals for patents, copyrights as well as cinematography under the Tribunals Reforms (Rationalisation and Conditions of Service) Bill, 2021. All disputes and appeals related to IP protection, including patents and trademarks in engineering, technology, pharmaceuticals, and chemicals are expected to be decided by the courts and not through the designated appellate tribunal if the new bill is passed.
Industry: Others
China Proposes New Rules for Patenting Drugs
shot by IP News Shots / 6:25 pm on 12 February, 2021
The China National Intellectual Property Administration (CNIPA) has proposed a new set of patenting rules for drugs. The changes relate to measures for enforcing a patent linkage system and how the approval of a drug can be challenged by a patent owner.
Read More at: https://www.lifesciencesipreview.com/news/china-unveils-new-drug-patenting-rules-4360
Industry: Pharmaceuticals
Drugmakers Need to Lower Prices or Risk Losing Patent Exclusivity
shot by IP News Shots / 6:02 pm on 29 January, 2021
As part of a demand for a Medicare drug pricing negotiation bill, the US Democratic leaders are seeking stricter measures against pharmaceutical companies that do not reduce drug prices, including rules like revocation of patent exclusivity if the drug makers do not comply with the pricing norms.
Read More at: https://news.bloomberglaw.com/health-law-and-business/progressives-seek-tougher-drugmaker-penalties-in-pricing-bill
Industry: Pharmaceuticals
Constitutional Complaints Bring UPC Ratification to a Halt
shot by IP News Shots / 6:21 pm on 15 January, 2021
The United Patent Court (UPC) ratification in Germany has faced another roadblock in the form of two constitutional complaints. The German Federal Constitutional Court (FCC) has received complaints. The first complaint was filed before the ratification was passed in both the Houses of Legislature and the second was filed by Foundation for a Free Information Infrastructure.
Read More at: https://www.worldipreview.com/news/upc-delayed-again-by-constitutional-complaints-20583
Industry: Others